Biotricity, Inc.
BTCY
$0.50
-$0.02-3.85%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -10.67M | -12.25M | -14.38M | -14.09M | -14.58M |
Total Depreciation and Amortization | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K |
Total Amortization of Deferred Charges | 2.37M | 2.50M | 2.76M | 2.17M | 2.17M |
Total Other Non-Cash Items | 1.59M | 2.05M | 2.25M | 1.54M | 1.77M |
Change in Net Operating Assets | 3.55M | 3.32M | 3.00M | 3.68M | 3.23M |
Cash from Operations | -3.15M | -4.36M | -6.36M | -6.69M | -7.41M |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | 2.20M | 1.69M | 2.76M | 3.82M | 4.89M |
Total Debt Repaid | -1.41M | -1.13M | -837.60K | -- | 61.20K |
Issuance of Common Stock | 125.20K | 125.20K | 244.50K | 119.30K | 119.30K |
Repurchase of Common Stock | 0.00 | -- | -- | -- | -- |
Issuance of Preferred Stock | 2.66M | 2.66M | 4.14M | 2.83M | 1.90M |
Repurchase of Preferred Stock | -- | -- | -- | -- | 0.00 |
Total Dividends Paid | -23.90K | -24.00K | -23.90K | -17.90K | -23.90K |
Other Financing Activities | 0.00 | -- | -- | -- | -- |
Cash from Financing | 3.55M | 3.32M | 6.28M | 6.74M | 6.95M |
Foreign Exchange rate Adjustments | 17.00K | 14.30K | 124.60K | 167.80K | 89.30K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 424.50K | -1.03M | 49.40K | 215.70K | -366.30K |